These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4078104)

  • 1. Age distribution and histologic patterns of dysplastic nevi.
    Sagebiel RW; Banda PW; Schneider JS; Crutcher WA
    J Am Acad Dermatol; 1985 Dec; 13(6):975-82. PubMed ID: 4078104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical diagnosis of dysplastic melanocytic nevi. A clinicopathologic correlation.
    Kelly JW; Crutcher WA; Sagebiel RW
    J Am Acad Dermatol; 1986 Jun; 14(6):1044-52. PubMed ID: 3722481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.
    Clark WH; Elder DE; Guerry D; Epstein MN; Greene MH; Van Horn M
    Hum Pathol; 1984 Dec; 15(12):1147-65. PubMed ID: 6500548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
    Skender-Kalnenas TM; English DR; Heenan PJ
    J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of histologic melanocytic dysplasia from clinical observation.
    Roush GC; Dubin N; Barnhill RL
    J Am Acad Dermatol; 1993 Oct; 29(4):555-62. PubMed ID: 8408790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma.
    Elder DE; Goldman LI; Goldman SC; Greene MH; Clark WH
    Cancer; 1980 Oct; 46(8):1787-94. PubMed ID: 7427881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
    Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG
    Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hypothesis incorporating the histologic characteristics of dysplastic nevi into the normal biological development of melanocytic nevi.
    Piepkorn M
    Arch Dermatol; 1990 Apr; 126(4):514-8. PubMed ID: 2321996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common acquired melanocytic nevi, melanocytic dysplasia and malignant melanoma. A morphometric study.
    Santucci M; Urso C; Giannini A; Bondi R
    Appl Pathol; 1989; 7(2):111-5. PubMed ID: 2730799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous melanoma risk and phenotypic changes in large congenital nevi: a follow-up study of 46 patients.
    Egan CL; Oliveria SA; Elenitsas R; Hanson J; Halpern AC
    J Am Acad Dermatol; 1998 Dec; 39(6):923-32. PubMed ID: 9843003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
    Serban ED; Farnetani F; Pellacani G; Constantin MM
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanocytic nevi, dysplastic nevi, and malignant melanoma in children from melanoma-prone families.
    Novakovic B; Clark WH; Fears TR; Fraser MC; Tucker MA
    J Am Acad Dermatol; 1995 Oct; 33(4):631-6. PubMed ID: 7673498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dysplastic nevus syndrome].
    Kint A
    Z Hautkr; 1986 May; 61(9):595-8. PubMed ID: 3716535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR; El-Zammar O
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of clinical pigmentary characteristics with histopathologically-confirmed dysplastic nevi in nonfamilial melanoma patients. Studies of melanocytic nevi IX.
    Roush GC; Barnhill RL
    Br J Cancer; 1991 Nov; 64(5):943-7. PubMed ID: 1931621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meyerson Phenomenon as a Component of Melanoma in situ.
    Sezer E; Özturk Durmaz E; Çetin E; Şahin S
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):81-2. PubMed ID: 27149137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant melanocytic lesions in infancy, childhood, and adolescence.
    Hoss DM; Grant-Kels JM
    Dermatol Clin; 1986 Jan; 4(1):29-44. PubMed ID: 3521978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas.
    Rhodes AR; Harrist TJ; Day CL; Mihm MC; Fitzpatrick TB; Sober AJ
    J Am Acad Dermatol; 1983 Oct; 9(4):563-74. PubMed ID: 6630618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
    Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
    Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nevic mitoses: a review of 1041 cases.
    O'Rourke EA; Balzer B; Barry CI; Frishberg DP
    Am J Dermatopathol; 2013 Feb; 35(1):30-3. PubMed ID: 22688393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.